Endo’s Response to COVID-19

For decades, people have trusted Endo to provide medicines which help them lead healthier lives.

As the global coronavirus (COVID-19) pandemic continues to evolve, our role in providing safe, high-quality products to the patients and providers who rely on us is more important than ever.

That’s why our team of more than 3,000 dedicated colleagues is focused on several key priorities right now.

Health and Safety of Our Employees

We have taken, and will continue to take, proactive measures to ensure the well-being of our team members around the globe while continuing to safely produce products upon which patients and their healthcare providers rely. We have implemented work from home requirements for team members who are able to do so. For those who continue to come to work, we have reduced operating staff, increased social distancing and enhanced our already rigorous sanitization efforts throughout all of our facilities. We are also limiting outside visitors and restricting global and domestic travel.

Commitment to Our Patients

We are committed to keeping our manufacturing sites open in order to provide patients with the high quality, medically necessary and life-saving products they require. We are actively monitoring and evaluating our supply chain in order to reliably continue supplying patients with our products.

Patients who have questions or concerns about their medications or treatment plan should consult with their healthcare provider. For additional questions or concerns, please contact the Endo Customer Service team at (800) 462-ENDO-(3636); Par Customer Service team at (800) 828-9393 or Paladin Customer Service team at (866) 340-1112.

Clinical Trials and R&D Efforts

We have a number of ongoing clinical trials, and we are committed to the safety of the patients and Endo team members involved. We are monitoring COVID-19 closely and continue to partner with the FDA on our ongoing regulatory applications, including clinical trials and R&D activities.

Last Updated: April 15, 2020.

For a French translation of this page, click here.